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Ductal carcinoma in situ ( D C I S )i san o n - o b l i g a t ep r e -
cursor to invasive ductal carcinoma (IDC). Identification
of the genetic differences between the two lesions may
assist in identifying genes that promote the invasive
phenotype. To annotate these alterations we analysed 21
breast tumours containing synchronous areas of DCIS
and IDC. Tumour cells were microdissected from FFPE
tissue and analysed by 300K Molecular Inversion Probe
( M I P )c o p yn u m b e ra r r a y s .M a t c h e dI D Ca n dD C I S
showed highly similar copy number profiles (average of
83% of the genome shared). Four regions of loss (3q, 6q,
8p and 11q) and four regions of gain (5q, 16p, 19q and
20) were recurrently affected in IDC but not in the
matching DCIS. CCND1 and MYC showed increased
amplitude of gain in IDC. One region of loss (17p11.2)
was specific to DCIS. Our data shows that DCIS is an
advanced pre-invasive tumour with genetic instability
and continues to evolve in parallel with co-existing IDC.
In the IDC-specific regions of genomic alteration we
have identified novel loci as well as genes with previous
links to breast cancer progression.
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